Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)
China
· Delayed Price · Currency is CNY 17.41
-0.06 (-0.34%)
Apr 30, 2026, 9:55 AM CST
SHA:603896 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 18.12 | 174.71 | 254.48 | 277.78 | 200.83 | Upgrade
|
| Depreciation & Amortization | 92.92 | 75.47 | 76.22 | 64.38 | 53.9 | Upgrade
|
| Other Amortization | 29.18 | 29.12 | 23.77 | 16.71 | 11.93 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.41 | -8.81 | -0.17 | -0.07 | -0.03 | Upgrade
|
| Asset Writedown & Restructuring Costs | -7.78 | 0.02 | 0.03 | 0.06 | 0 | Upgrade
|
| Loss (Gain) From Sale of Investments | -3.76 | -7.41 | -3.95 | -3.28 | 5.49 | Upgrade
|
| Provision & Write-off of Bad Debts | - | -0.1 | -1.22 | 1.57 | 0.78 | Upgrade
|
| Other Operating Activities | 16.52 | 20.57 | 16.9 | 10.55 | 9.93 | Upgrade
|
| Change in Accounts Receivable | -15.02 | -34.93 | -18.97 | -16.19 | -27.9 | Upgrade
|
| Change in Inventory | -27.22 | -21.72 | -10.08 | -48.69 | 0.32 | Upgrade
|
| Change in Accounts Payable | 131.71 | -13.52 | -22.69 | 38.69 | 36.4 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | - | 4.39 | Upgrade
|
| Operating Cash Flow | 228.07 | 213.44 | 315.06 | 341.28 | 296.7 | Upgrade
|
| Operating Cash Flow Growth | 6.86% | -32.25% | -7.69% | 15.03% | 15.74% | Upgrade
|
| Capital Expenditures | -273.22 | -507.06 | -414.54 | -182.6 | -161.63 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.04 | 227.58 | 0.11 | 0.24 | 0.05 | Upgrade
|
| Cash Acquisitions | - | - | -0.01 | - | - | Upgrade
|
| Divestitures | - | - | - | -1.05 | - | Upgrade
|
| Investment in Securities | -13.91 | 37.12 | -886.89 | 95.55 | -74.6 | Upgrade
|
| Other Investing Activities | 2.77 | 2.6 | 2.54 | 2.47 | 2.45 | Upgrade
|
| Investing Cash Flow | -284.32 | -239.76 | -1,299 | -85.39 | -233.72 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 661.94 | - | Upgrade
|
| Long-Term Debt Issued | 456.8 | 430.51 | 737.44 | - | - | Upgrade
|
| Total Debt Issued | 456.8 | 430.51 | 737.44 | 661.94 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -0.02 | Upgrade
|
| Long-Term Debt Repaid | -418.01 | -590.9 | -609.58 | -9.98 | -5.52 | Upgrade
|
| Total Debt Repaid | -418.01 | -590.9 | -609.58 | -9.98 | -5.54 | Upgrade
|
| Net Debt Issued (Repaid) | 38.79 | -160.38 | 127.86 | 651.96 | -5.54 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -2.1 | Upgrade
|
| Common Dividends Paid | -59.5 | -83 | -92.78 | -61.12 | -47.51 | Upgrade
|
| Other Financing Activities | -17.62 | - | 255 | -255 | 0.9 | Upgrade
|
| Financing Cash Flow | -38.33 | -243.38 | 290.08 | 335.84 | -54.24 | Upgrade
|
| Net Cash Flow | -94.57 | -269.7 | -693.64 | 591.73 | 8.74 | Upgrade
|
| Free Cash Flow | -45.15 | -293.62 | -99.48 | 158.68 | 135.07 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 17.48% | -29.42% | Upgrade
|
| Free Cash Flow Margin | -7.05% | -42.45% | -12.68% | 19.14% | 17.61% | Upgrade
|
| Free Cash Flow Per Share | -0.22 | -1.48 | -0.51 | 0.82 | 0.71 | Upgrade
|
| Cash Income Tax Paid | 48.91 | 39.45 | 46.41 | 51.43 | 64.36 | Upgrade
|
| Levered Free Cash Flow | 61.3 | -370.44 | -198.9 | -24.34 | 12.62 | Upgrade
|
| Unlevered Free Cash Flow | 61.3 | -361.21 | -183.46 | -16.19 | 18.97 | Upgrade
|
| Change in Working Capital | 83.27 | -70.14 | -51 | -26.41 | 13.87 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.